<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: An upper age limit for screening mammography?</title>
	<atom:link href="http://www.kevinmd.com/blog/2008/04/upper-age-limit-for-screening.html/feed" rel="self" type="application/rss+xml" />
	<link>http://www.kevinmd.com/blog/2008/04/upper-age-limit-for-screening.html</link>
	<description>medical blog</description>
	<lastBuildDate>Mon, 23 Nov 2009 01:35:28 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Anonymous</title>
		<link>http://www.kevinmd.com/blog/2008/04/upper-age-limit-for-screening.html/comment-page-1#comment-85235</link>
		<dc:creator>Anonymous</dc:creator>
		<pubDate>Thu, 24 Apr 2008 14:50:00 +0000</pubDate>
		<guid isPermaLink="false">http://clients.emmense.com/kevinmd/2008/04/an-upper-age-limit-for-screening-mammography.html#comment-85235</guid>
		<description>&lt;i&gt;Five-year breast cancer-specific survival rates were 94% for regular mammography users, 88% for irregular users, and 82% for nonusers (P&lt;0.0001). &lt;/i&gt;&lt;br/&gt;Does anyone of these researchers understand lead-time bias? overdiagnosis bias? length bias? 5-year survival numbers ONLY make sense when you start from the same point of origin. If a train crashes in Miami, I take it in NYC and you take it in Washington, then my survival is longer. Yet you wouldn&#039;t say I am better off? &lt;br/&gt;&lt;br/&gt;Any screening, regardless of whether or not it saves lives results in improved 5-year survival rates. I bet neuroblastoma screening in Japan - a major fiasco that failed to save a single kid but harmed a few - also increased survival rates by simply increasing the number of diagnosed cases.&lt;br/&gt;&lt;br/&gt;How can published researchers continue to ignore lead-time bias? ONLY comparison of numbers of people who died of breast cancer in screened vs not screened group makes sense when evaluating if screening has benefit.</description>
		<content:encoded><![CDATA[<p><i>Five-year breast cancer-specific survival rates were 94% for regular mammography users, 88% for irregular users, and 82% for nonusers (P&lt;0.0001). </i><br />Does anyone of these researchers understand lead-time bias? overdiagnosis bias? length bias? 5-year survival numbers ONLY make sense when you start from the same point of origin. If a train crashes in Miami, I take it in NYC and you take it in Washington, then my survival is longer. Yet you wouldn&#8217;t say I am better off? </p>
<p>Any screening, regardless of whether or not it saves lives results in improved 5-year survival rates. I bet neuroblastoma screening in Japan &#8211; a major fiasco that failed to save a single kid but harmed a few &#8211; also increased survival rates by simply increasing the number of diagnosed cases.</p>
<p>How can published researchers continue to ignore lead-time bias? ONLY comparison of numbers of people who died of breast cancer in screened vs not screened group makes sense when evaluating if screening has benefit.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
